Disclosure of notification received from Templeton Investment Counsel, LLC
21 9월 2022 - 2:00AM
Disclosure of notification received from Templeton Investment
Counsel, LLC
Regulated informationNazareth (Belgium)/Rotterdam
(The Netherlands), 20 September 2022 – 7:00 PM CET
Disclosure of notification received from
Templeton Investment Counsel, LLC
Pursuant to the Belgian law of 2 May 2007 regarding
the disclosure of major shareholdings in listed companies, Fagron
received a notification from Templeton Investment Counsel, LLC.
Notification Templeton Investment Counsel,
LLC
- On 14 September 2022, Fagron received a notification that the
shareholding of Templeton Investment Counsel, LLC had crossed the
lowest disclosure threshold of 3% on 13 September 2022 as the
result of the disposal of voting securities or voting rights.
- The notification is made by a ‘person that notifies
alone’.
- On 13 September 2022, Templeton Investment Counsel, LLC held a
total of 2,136,016 voting rights.
- Based on the denominator of 72,992,654 (total number of voting
rights), Templeton Investment Counsel, LLC held 2.93% of the total
number of voting rights on 13 September 2022.
- Templeton Investment Counsel, LLC is a wholly owned subsidiary
of Templeton Worldwide Inc., which is a wholly owned subsidiary of
Franklin Resources, Inc.
- Templeton Investment Counsel, LLC makes use of the exemption
from the obligation to aggregate its holdings, as referred to in
Article 11, paragraph 2 of the Law of 2 May 2007, and Article 21 of
the Royal Decree of 14 February 2008.
- As a result of a change in the investment management agreement,
Templeton Investment Counsel, LLC, no longer retains the voting
authority over the shares of its client account, and this led to a
reduction of the voting interest of Templeton Investment Counsel,
LLC in Fagron. The client now retains the responsibility to vote
the shares.
- The notification of Templeton Investment Counsel, LLC can be
viewed via this link.
Further informationKaren BergGlobal Investor
Relations ManagerTel. +31 6 53 44 91 99karen.berg@fagron.com
About FagronFagron is a leading global company
active in pharmaceutical compounding, focusing on delivering
personalized medicine to hospitals, pharmacies, clinics, and
patients in 35 countries around the world.
Belgian company Fagron NV has its registered office
in Nazareth and is listed on Euronext Brussels and Euronext
Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational
activities are managed by the Dutch company Fagron BV, which is
headquartered in Rotterdam.
In the event of differences between the English
translation and the Dutch original of this press release, the
latter prevails.
Please open the link below for the press
release:Disclosure of notification received from Templeton
Investment Counsel, LLC
Fagron NV (EU:FAGR)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Fagron NV (EU:FAGR)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024